ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $368,000 | -63.8% | 26,500 | -26.8% | 0.00% | -66.7% |
| Q4 2021 | $1,016,000 | -13.3% | 36,200 | +24.3% | 0.01% | -35.7% |
| Q1 2021 | $1,172,000 | -51.8% | 29,112 | -41.8% | 0.01% | -69.6% |
| Q3 2020 | $2,432,000 | +19.0% | 50,000 | +18.5% | 0.05% | +70.4% |
| Q2 2020 | $2,044,000 | +121.0% | 42,200 | +41.1% | 0.03% | 0.0% |
| Q3 2019 | $925,000 | -83.6% | 29,900 | -74.4% | 0.03% | -86.5% |
| Q2 2019 | $5,644,000 | – | 116,845 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |